Radiotherapy plus hormone therapy cuts prostate cancer death in half, shows long-term study

Combination treatment more than halves mortality rates for prostate cancer, reports Norwegian health journal Dagens Medisin.The figures were presented by Norwegian cancer researcher Sophie Fosså at an international conference sponsored by the American Society of Clinical Oncology (ASCO) in San Francisco this week.By adding radiotherapy to the standard hormone treatment against prostate cancer, the 10 to 15 year survival rate for men with prostate cancer more than doubled, according to a long term follow-up study where Dr. Sophie Fosså is lead author.